Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Phylogeny | 25 | 2021 | 13341 | 0.83 | Why? |
| Bayes Theorem | 8 | 2020 | 3237 | 0.61 | Why? |
| Genome, Viral | 24 | 2021 | 13157 | 0.58 | Why? |
| Evolution, Molecular | 12 | 2021 | 3691 | 0.55 | Why? |
| Software | 3 | 2019 | 2501 | 0.47 | Why? |
| Models, Genetic | 4 | 2020 | 434 | 0.37 | Why? |
| Genomics | 4 | 2021 | 3118 | 0.30 | Why? |
| Molecular Epidemiology | 6 | 2021 | 1638 | 0.29 | Why? |
| Biological Evolution | 3 | 2020 | 641 | 0.29 | Why? |
| Selection, Genetic | 3 | 2020 | 691 | 0.27 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2008 | 572 | 0.26 | Why? |
| Markov Chains | 3 | 2019 | 502 | 0.23 | Why? |
| Monte Carlo Method | 3 | 2019 | 577 | 0.22 | Why? |
| Zoonoses | 4 | 2020 | 3034 | 0.22 | Why? |
| Genetic Variation | 6 | 2021 | 3919 | 0.22 | Why? |
| Ebolavirus | 2 | 2018 | 834 | 0.22 | Why? |
| Sequence Analysis, DNA | 4 | 2021 | 2830 | 0.21 | Why? |
| Immune Evasion | 2 | 2021 | 2081 | 0.21 | Why? |
| Cloud Computing | 1 | 2021 | 214 | 0.19 | Why? |
| Spike Glycoprotein, Coronavirus | 8 | 2021 | 37182 | 0.19 | Why? |
| Genetic Fitness | 1 | 2021 | 339 | 0.18 | Why? |
| Hemorrhagic Fever, Ebola | 3 | 2018 | 1475 | 0.18 | Why? |
| Sequence Deletion | 1 | 2020 | 674 | 0.15 | Why? |
| Terminology as Topic | 1 | 2021 | 546 | 0.15 | Why? |
| Communicable Diseases, Imported | 2 | 2021 | 843 | 0.14 | Why? |
| Betacoronavirus | 12 | 2020 | 204454 | 0.14 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2017 | 2984 | 0.14 | Why? |
| Epidemiology | 1 | 2017 | 216 | 0.14 | Why? |
| Coronavirus Infections | 20 | 2020 | 253789 | 0.13 | Why? |
| Likelihood Functions | 3 | 2020 | 719 | 0.13 | Why? |
| Amino Acid Substitution | 1 | 2020 | 1706 | 0.13 | Why? |
| Travel | 6 | 2021 | 7220 | 0.13 | Why? |
| Influenza in Birds | 1 | 2018 | 528 | 0.12 | Why? |
| Influenza, Human | 3 | 2018 | 10779 | 0.12 | Why? |
| Capacity Building | 1 | 2018 | 683 | 0.12 | Why? |
| Phylogeography | 3 | 2021 | 824 | 0.12 | Why? |
| Camelus | 2 | 2018 | 1425 | 0.12 | Why? |
| Models, Immunological | 1 | 2017 | 727 | 0.11 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 3 | 2018 | 8843 | 0.11 | Why? |
| Pneumonia, Viral | 12 | 2020 | 243684 | 0.10 | Why? |
| Whole Genome Sequencing | 4 | 2021 | 3239 | 0.10 | Why? |
| Communicable Diseases, Emerging | 2 | 2021 | 2523 | 0.10 | Why? |
| Genetic Drift | 1 | 2008 | 54 | 0.09 | Why? |
| Mutation | 7 | 2021 | 12376 | 0.09 | Why? |
| Genotype | 1 | 2020 | 4697 | 0.09 | Why? |
| Community-Acquired Infections | 1 | 2020 | 2328 | 0.09 | Why? |
| Viruses | 2 | 2018 | 2238 | 0.09 | Why? |
| Base Sequence | 4 | 2020 | 3581 | 0.08 | Why? |
| Coronavirus | 5 | 2014 | 18339 | 0.08 | Why? |
| Cluster Analysis | 4 | 2018 | 3001 | 0.08 | Why? |
| Humans | 40 | 2021 | 930598 | 0.08 | Why? |
| Epidemiological Monitoring | 4 | 2021 | 3493 | 0.08 | Why? |
| Models, Statistical | 2 | 2020 | 5312 | 0.08 | Why? |
| Reassortant Viruses | 1 | 2008 | 287 | 0.08 | Why? |
| Neuraminidase | 1 | 2008 | 289 | 0.08 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.08 | Why? |
| Basic Reproduction Number | 4 | 2021 | 2676 | 0.08 | Why? |
| Models, Biological | 2 | 2017 | 4907 | 0.07 | Why? |
| Disease Outbreaks | 5 | 2018 | 27595 | 0.07 | Why? |
| Survivors | 1 | 2018 | 2619 | 0.07 | Why? |
| Models, Theoretical | 2 | 2021 | 6659 | 0.07 | Why? |
| International Cooperation | 1 | 2018 | 3436 | 0.07 | Why? |
| Spatio-Temporal Analysis | 2 | 2021 | 1182 | 0.07 | Why? |
| Zika Virus | 1 | 2017 | 1924 | 0.07 | Why? |
| Molecular Sequence Data | 3 | 2014 | 3198 | 0.07 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2008 | 511 | 0.07 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.06 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.06 | Why? |
| Virulence | 2 | 2021 | 2172 | 0.06 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.06 | Why? |
| Respiratory Tract Infections | 2 | 2013 | 6817 | 0.06 | Why? |
| Brazil | 4 | 2021 | 12582 | 0.06 | Why? |
| Pandemics | 14 | 2020 | 389249 | 0.06 | Why? |
| Animals | 10 | 2020 | 78931 | 0.06 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.06 | Why? |
| Databases, Nucleic Acid | 1 | 2004 | 272 | 0.06 | Why? |
| RNA, Viral | 3 | 2014 | 32276 | 0.06 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.05 | Why? |
| Aspartic Acid | 1 | 2020 | 76 | 0.05 | Why? |
| New Zealand | 1 | 2008 | 2073 | 0.05 | Why? |
| Netherlands | 2 | 2020 | 3533 | 0.05 | Why? |
| RNA Cleavage | 1 | 2020 | 35 | 0.05 | Why? |
| SARS Virus | 1 | 2004 | 13021 | 0.05 | Why? |
| United Kingdom | 4 | 2021 | 18046 | 0.05 | Why? |
| Antigenic Variation | 1 | 2021 | 249 | 0.05 | Why? |
| Cross Infection | 2 | 2020 | 8675 | 0.05 | Why? |
| Species Specificity | 1 | 2004 | 1356 | 0.05 | Why? |
| New York | 1 | 2008 | 2488 | 0.05 | Why? |
| Protein Conformation | 2 | 2021 | 4386 | 0.05 | Why? |
| Antigens, Viral | 1 | 2017 | 6298 | 0.05 | Why? |
| Glycine | 1 | 2020 | 203 | 0.05 | Why? |
| Amino Acid Motifs | 1 | 2021 | 620 | 0.05 | Why? |
| Adaptation, Biological | 1 | 2020 | 179 | 0.05 | Why? |
| Chiroptera | 3 | 2020 | 3530 | 0.05 | Why? |
| Saudi Arabia | 3 | 2014 | 4423 | 0.05 | Why? |
| Sequence Analysis | 1 | 2020 | 496 | 0.05 | Why? |
| Congo | 1 | 2018 | 131 | 0.05 | Why? |
| Epidemics | 2 | 2021 | 6407 | 0.04 | Why? |
| Mammals | 1 | 2020 | 315 | 0.04 | Why? |
| Honduras | 1 | 2017 | 117 | 0.04 | Why? |
| Uganda | 1 | 2021 | 1057 | 0.04 | Why? |
| Amino Acids | 1 | 2021 | 552 | 0.04 | Why? |
| Africa, Western | 1 | 2018 | 363 | 0.04 | Why? |
| Puerto Rico | 1 | 2017 | 177 | 0.04 | Why? |
| World Health Organization | 2 | 2021 | 4213 | 0.04 | Why? |
| Geographic Mapping | 1 | 2017 | 247 | 0.04 | Why? |
| Biostatistics | 1 | 2017 | 116 | 0.04 | Why? |
| Birds | 1 | 2018 | 412 | 0.04 | Why? |
| Host Specificity | 1 | 2020 | 926 | 0.04 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 3633 | 0.04 | Why? |
| Culicidae | 1 | 2017 | 239 | 0.04 | Why? |
| Washington | 1 | 2020 | 1722 | 0.04 | Why? |
| Stochastic Processes | 1 | 2017 | 369 | 0.04 | Why? |
| Metagenome | 1 | 2017 | 268 | 0.04 | Why? |
| Computer Simulation | 2 | 2020 | 4982 | 0.03 | Why? |
| User-Computer Interface | 1 | 2021 | 1068 | 0.03 | Why? |
| Mosquito Vectors | 1 | 2017 | 351 | 0.03 | Why? |
| Gene Amplification | 1 | 2013 | 85 | 0.03 | Why? |
| Europe | 2 | 2020 | 12702 | 0.03 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.03 | Why? |
| Air Travel | 1 | 2020 | 585 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2020 | 1265 | 0.03 | Why? |
| Virus Replication | 3 | 2020 | 14331 | 0.03 | Why? |
| Virus Activation | 1 | 2018 | 480 | 0.03 | Why? |
| China | 4 | 2020 | 50654 | 0.03 | Why? |
| Furin | 1 | 2020 | 1054 | 0.03 | Why? |
| Computational Biology | 2 | 2019 | 4514 | 0.03 | Why? |
| Virus Attachment | 1 | 2020 | 1259 | 0.03 | Why? |
| Colombia | 1 | 2017 | 1241 | 0.03 | Why? |
| Polysaccharides | 1 | 2020 | 854 | 0.03 | Why? |
| Semen | 1 | 2018 | 550 | 0.03 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2020 | 1609 | 0.03 | Why? |
| Geography | 1 | 2018 | 1801 | 0.03 | Why? |
| Germany | 2 | 2020 | 9196 | 0.03 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.03 | Why? |
| Age Distribution | 1 | 2021 | 3567 | 0.03 | Why? |
| DNA, Complementary | 1 | 2013 | 568 | 0.03 | Why? |
| United Arab Emirates | 1 | 2013 | 704 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Animals, Wild | 1 | 2018 | 1028 | 0.03 | Why? |
| Qatar | 1 | 2013 | 784 | 0.03 | Why? |
| Jordan | 1 | 2013 | 701 | 0.03 | Why? |
| Mass Screening | 2 | 2020 | 8005 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Urban Population | 1 | 2020 | 2000 | 0.02 | Why? |
| England | 1 | 2021 | 5116 | 0.02 | Why? |
| Africa | 1 | 2018 | 2986 | 0.02 | Why? |
| Middle East | 1 | 2013 | 1418 | 0.02 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2020 | 6049 | 0.02 | Why? |
| DNA Primers | 1 | 2013 | 1170 | 0.02 | Why? |
| Syndrome | 1 | 2013 | 1310 | 0.02 | Why? |
| Cities | 1 | 2020 | 4937 | 0.02 | Why? |
| Trust | 1 | 2018 | 1487 | 0.02 | Why? |
| Aged | 6 | 2021 | 215776 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2020 | 3755 | 0.02 | Why? |
| Models, Molecular | 1 | 2020 | 7616 | 0.02 | Why? |
| Environmental Monitoring | 1 | 2018 | 3143 | 0.02 | Why? |
| Cell Line | 1 | 2020 | 12040 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2017 | 3129 | 0.02 | Why? |
| Fatal Outcome | 1 | 2013 | 3438 | 0.02 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Communication | 1 | 2021 | 5206 | 0.02 | Why? |
| Shock, Septic | 1 | 2013 | 1313 | 0.02 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.01 | Why? |
| Influenza Vaccines | 1 | 2018 | 2941 | 0.01 | Why? |
| Spain | 1 | 2020 | 15545 | 0.01 | Why? |
| Anti-Infective Agents | 1 | 2013 | 1766 | 0.01 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.01 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2014 | 3607 | 0.01 | Why? |
| Adult | 4 | 2021 | 244371 | 0.01 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.01 | Why? |
| Survival Analysis | 1 | 2013 | 7592 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Feces | 1 | 2013 | 4235 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Virus Diseases | 1 | 2017 | 3779 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Male | 4 | 2020 | 367725 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.01 | Why? |
| Italy | 1 | 2020 | 38444 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Female | 3 | 2020 | 380317 | 0.01 | Why? |
| United States | 1 | 2017 | 46150 | 0.01 | Why? |
| Risk Assessment | 1 | 2013 | 25439 | 0.01 | Why? |
| Lung | 1 | 2018 | 31049 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
| Antiviral Agents | 1 | 2013 | 41703 | 0.00 | Why? |
Rambaut's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(203)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(606)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_